CXCR4 - C-X-C motif chemokine receptor 4 Gene
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 396659
About CXCR4
Primary_assembly 15: 15,663,494-15,667,232 forward strand.Sscrofa11.1:CM000826.5
This gene has 1 transcript (splice variant), 285 orthologues and 22 paralogues.
CXCR4 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_213773.1 | NP_998938.1 | C-X-C chemokine receptor type 4 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
C-X-C chemokine receptor type 4 |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10046 | Plerixafor | Antagonist | 99.90% | Yes |
| HY-50912 | Plerixafor octahydrochloride | Antagonist | 99.09% | Yes |
| HY-P0171 | Motixafortide | Antagonist | 99.76% | Unkown |
| HY-50101A | Mavorixafor trihydrochloride | Antagonist | 99.75% | Yes |
| HY-50101 | Mavorixafor | Antagonist | 99.72% | Yes |
| HY-50101C | Mavorixafor hydrochloride | Antagonist | 99.64% | Unkown |
Clinical Phase
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P1682A | Balixafortide TFA | Antagonist | 99.89% | Phase 3 |
| HY-P1682 | Balixafortide | Antagonist | 98.20% | Phase 3 |
| HY-12488 | LY2510924 | Inhibitor | 99.85% | Phase 2 |
| HY-19867A | Burixafor hydrobromide | Antagonist | 99.70% | Phase 2 |
| HY-P1103 | CTCE-9908 | Antagonist | 99.54% | Phase 2 |
| HY-114244 | USL311 | Antagonist | 99.97% | Phase 2 |
| HY-19867 | Burixafor | Antagonist | / | Phase 2 |
| HY-13696 | MSX-122 | Antagonist | 98.16% | Phase 1 |
Inhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99272 | Ulocuplumab | Antagonist | 99.90% | Phase 3 |
| HY-P991656 | LY-2624587 | Antagonist | / | Phase 1 |
| HY-P991647 | ALX-0651 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(57)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0011 | Baohuoside I | Inhibitor | 99.94% | Unkown |
| HY-W087028 | NOTA-NHS ester | ≥97.0% | Unkown | |
| HY-101458A | IT1t dihydrochloride | Antagonist | 99.77% | Unkown |
| HY-111793A | NUCC-390 dihydrochloride | Agonist | 98.19% | Unkown |
| HY-P3612 | CTCE-0214 | Agonist | 99.96% | Unkown |
| HY-P1104A | FC131 TFA | Antagonist | 99.87% | Unkown |
| HY-15478 | WZ811 | Antagonist | 99.80% | Unkown |
| HY-P1102 | TC14012 | Modulator | 99.77% | Unkown |
| HY-D0976 | NF279 | Antagonist | 98.5% | Unkown |
| HY-111793 | NUCC-390 | Agonist | 98.01% | Unkown |
| HY-P10415 | EPI-X4 | Antagonist | 98.91% | Unkown |
| HY-15971A | AMD 3465 | Antagonist | 98.24% | Unkown |
| HY-15971 | AMD 3465 hexahydrobromide | Antagonist | 98.0% | Unkown |
| HY-P7061A | ALX 40-4C Trifluoroacetate | Inhibitor | 99.78% | Unkown |
| HY-122058A | KRH-3955 hydrochloride | Antagonist | / | Unkown |
| HY-161735 | CXCR4-IN-3 | Inhibitor | 99.69% | Unkown |
| HY-167851 | CCX662 | Inhibitor | 98.62% | Unkown |
| HY-P0172 | ATI-2341 | Agonist | 99.64% | Unkown |
| HY-146413 | HF50731 | Antagonist | 99.66% | Unkown |
| HY-147978 | CXCR4 antagonist 8 | Antagonist | 99.88% | Unkown |
| HY-146372 | CXCR4 antagonist 5 | Antagonist | / | Unkown |
| HY-P4111A | Peptide R TFA | Antagonist | 98.34% | Unkown |
| HY-P7061 | ALX 40-4C | Inhibitor | / | Unkown |
| HY-P10971 | Nef-M1 | Antagonist | 98.87% | Unkown |
| HY-146054 | CXCR4 modulator-2 | Modulator | / | Unkown |
| HY-P10973 | Peptide R analogue 10 | Antagonist | 99.47% | Unkown |
| HY-103010 | MSX-130 | Antagonist | 98.00% | Unkown |
| HY-P4111 | Peptide R | Antagonist | / | Unkown |
| HY-168095 | CXCR4 antagonist 10 | Inhibitor | 99.27% | Unkown |
| HY-P1104 | FC131 | Antagonist | / | Unkown |
| HY-101458 | IT1t | Antagonist | / | Unkown |
| HY-147979 | CXCR4 antagonist 9 | Antagonist | / | Unkown |
| HY-P11011A | Peptide R54 acetate | Antagonist | 99.88% | Unkown |
| HY-162632 | Hit 14 | Inhibitor | ≥99.0% | Unkown |
| HY-103009 | MSX-127 | Antagonist | 99.68% | Unkown |
| HY-183994 | HL82624 | Agonist | / | Unkown |
| HY-148640 | WK500B | Activator | / | Unkown |
| HY-146401 | CXCR4 antagonist 6 | Antagonist | / | Unkown |
| HY-144286 | CXCR4 antagonist 3 | Inhibitor | / | Unkown |
| HY-P11019 | IS4 | Antagonist | / | Unkown |
| HY-178205 | BPRCX807 | Antagonist | / | Unkown |
| HY-129094 | ICT5040 | Antagonist | / | Unkown |
| HY-P11451 | Pentixather | / | Unkown | |
| HY-146053 | CXCR4 modulator-1 | Modulator | / | Unkown |
| HY-P1102A | TC14012 TFA | Modulator | / | Unkown |
| HY-P1103A | CTCE-9908 TFA | Antagonist | / | Unkown |
| HY-P11011 | Peptide R54 | Antagonist | / | Unkown |
| HY-P10427 | DV1 | Antagonist | / | Unkown |
| HY-136437 | CXCR4 antagonist 1 | Antagonist | / | Unkown |
| HY-182850 | UCUF-965 | Modulator | / | Unkown |
| HY-P10429 | RCP168 | Antagonist | / | Unkown |
| HY-N9858 | Herpetin | Activator | / | Unkown |
| HY-177799 | BPRCX 714 | Antagonist | / | Unkown |
| HY-147808 | CXCR4 antagonist 7 | Antagonist | / | Unkown |
| HY-115493 | TIQ-15 | Antagonist | / | Unkown |
| HY-144285 | CXCR4 antagonist 4 | Antagonist | / | Unkown |
| HY-123819 | KRH-1636 | Antagonist | / | Unkown |
Inhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991568 | AT009 | Modulator | / | Unkown |
| HY-P991744 | Anti-Mouse CXCR4 Antibody (Cx4Mab-1) | / | Unkown | |
| HY-P992439 | PF-06747143 | Inhibitor | / | Unkown |
| HY-P992405 | MEDI-3185 | Antagonist | / | Unkown |
| HY-P992397 | KY1051 | Inhibitor | / | Unkown |